Melania Rivano

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 18

Top Topics

Multiple Myeloma

Acute Lymphoblastic Leukemia

Top Venues

Hematology reports

European journal of hospital pharmacy : science and practice

This page only lists publications with an associated author ORCID identifier.

Publications

Melania Rivano, Daniele Mengato, Marco Chiumente, Andrea Messori
Low-Intensity and Chemo-Free Treatments in Ph+ ALL: Progression-Free Survival Based on Indirect Comparisons. Hematology reports 15 (4) (2023)
Maria Elisabetta Uda, Melania Rivano, Lucia Aledda, Maria Antonietta Maioli, Fabio Lombardo
Budget impact analysis: comparing the costs of nusinersen and risdiplam in the treatment of type 3 spinal muscular atrophy patients. European journal of hospital pharmacy : science and practice (2023)
Luca Cancanelli, Melania Rivano, Lorenzo Di Spazio, Marco Chiumente, Daniele Mengato, Andrea Messori
Survival in Patients with Relapsed-Refractory Multiple Myeloma: Indirect Comparison of Six New Treatments. Hematology reports 15 (1) (2023)
Andrea Messori, Vera Damuzzo, Melania Rivano, Luca Cancanelli, Lorenzo Di Spazio, Andrea Ossato, Marco Chiumente, Daniele Mengato
Application of the IPDfromKM-Shiny Method to Compare the Efficacy of Novel Treatments Aimed at the Same Disease Condition: A Report of 14 Analyses. Cancers 15 (6) (2023)
Melania Rivano, Daniele Mengato, Marco Chiumente, Andrea Messori
Low-Intensity and Chemo-Free Treatments in Ph+ ALL: Progression-Free Survival Based on Indirect Comparisons. Hematology reports 15 (4) (2023)
Luca Cancanelli, Melania Rivano, Lorenzo Di Spazio, Marco Chiumente, Daniele Mengato, Andrea Messori
Survival in Patients with Relapsed-Refractory Multiple Myeloma: Indirect Comparison of Six New Treatments. Hematology reports 15 (1) (2023)
Luca Cancanelli, Melania Rivano, Lorenzo Di Spazio, Marco Chiumente, Daniele Mengato, Andrea Messori
Survival in Patients with Relapsed-Refractory Multiple Myeloma: Indirect Comparison of Six New Treatments. Hematology reports 15 (1) (2023)
Andrea Messori, Vera Damuzzo, Melania Rivano, Luca Cancanelli, Lorenzo Di Spazio, Andrea Ossato, Marco Chiumente, Daniele Mengato
Application of the IPDfromKM-Shiny Method to Compare the Efficacy of Novel Treatments Aimed at the Same Disease Condition: A Report of 14 Analyses. Cancers 15 (6) (2023)
Melania Rivano, Daniele Mengato, Marco Chiumente, Andrea Messori
Low-Intensity and Chemo-Free Treatments in Ph+ ALL: Progression-Free Survival Based on Indirect Comparisons. Hematology reports 15 (4) (2023)
Daniele Mengato, Luca Cancanelli, Melania Rivano, Marco Chiumente, Lorenzo Di Spazio, Andrea Messori
First-line chemoimmunotherapy versus chemotherapy in PD-L1-negative patients with non-small-cell lung cancer. Immunotherapy 14 (11) (2022)
Melania Rivano, Luca Cancanelli, Lorenzo Di Spazio, Daniele Mengato, Marco Chiumente, Andrea Messori
Survival with novel hormonal therapies in patients with nonmetastatic castration-resistant prostate cancer: indirect comparison of three randomized phase-III trials. World journal of urology 40 (11) (2022)
Vera Damuzzo, Riccardo Bertin, Daniele Mengato, Marco Chiumente, Melania Rivano, Angelo Claudio Palozzo
COVID-19 impact on skills and professional perceptions of the hospital pharmacist during the first outbreak wave. European journal of hospital pharmacy : science and practice (2021)
Andrea Messori, Melania Rivano, Daniele Mengato, Luca Cancanelli, Lorenzo Di Spazio, Marco Chiumente
A preliminary estimate of survival gain and cost-effectiveness of CAR-T in adult patients with acute lymphoblastic leukemia. Leukemia & lymphoma 63 (5) (2021)
Marco Chiumente, Melania Rivano, Debora Severino, Sara Bertoli, Anna Rita Gasbarro, Rossella Santeramo, Alessandra Pasqualini, Riccardo Provasi, Daniele Mengato, Angelo Claudio Palozzo
Oncostability: stability of reconstituted and diluted anticancer medicines for a possible extension of use. European journal of hospital pharmacy : science and practice (2021)
Vera Damuzzo, Riccardo Bertin, Daniele Mengato, Marco Chiumente, Melania Rivano, Angelo Claudio Palozzo
Hospital Pharmacy Response to Covid-19 Pandemic in Italy: What We Learned From the First Outbreak Wave. Journal of pharmacy practice (2021)
Melania Rivano, Luca Cancanelli, Lorenzo Di Spazio, Marco Chiumente, Daniele Mengato, Andrea Messori
Restricted mean survival time as outcome measure in advanced urothelial bladder cancer: analysis of 4 clinical studies. Immunotherapy 13 (2) (2020)
Melania Rivano, Luca Cancanelli, Andrea Zovi, Chiara Addis, Daniele Mengato, Marco Chiumente, Andrea Messori
Tyrosine-kinase inhibitor discontinuation in chronic myeloid leukaemia after deep molecular response: a meta-analysis with meta-regression. Journal of chemotherapy (Florence, Italy) 32 (5) (2020)
Melania Rivano, Maria Albrecht, Giorgia Longobardo, Cinzia Veneziano
Galenic Preparation of 40% Dextrose Gel: A New Approach to the Management of Neonatal Hypoglycemia. Clinical medicine insights. Endocrinology and diabetes 13 (2020)